Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Lymphoma 4Hodgkin Disease 2Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Extensive Stage Small Cell Lung Cancer 1Congenital Abnormalities 1Central Nervous System Neoplasms 1Carcinoma, Small Cell 1Carcinoma, Neuroendocrine 1Burkitt Lymphoma 1Brain Neoplasms 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 28Peripheral Blood Stem Cell Transplantation 25Cyclophosphamide 24Whole-Body Irradiation 22Busulfan 22Tacrolimus 19Mycophenolic Acid 19Methotrexate 15Antilymphocyte Serum 13Cyclosporine 12Melphalan 9Filgrastim 9Cytarabine 9Etoposide 8Cord Blood Stem Cell Transplantation 7fludarabine 6Thiotepa 6Methylprednisolone 6Imatinib Mesylate 5Granulocyte Colony-Stimulating Factor 5thymoglobulin 4merphos 4Sirolimus 4Rituximab 4Radiotherapy 4Flow Cytometry 4Dexamethasone 4Dasatinib 4Cyclosporins 4Calcium Dobesilate 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Blast Crisis × Podophyllotoxin × Clear all
NCT00540995 2023-11-30

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

City of Hope Medical Center

Phase 1/2 Terminated
25 enrolled 9 charts
Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡